Inferra AIResearch Tools

Inferra AI / Company / CME

CME Group

CME · Financials

Last earnings Oct 21, 2026

Key results

Revenuequarter

$1.5 billion

The company reported revenue of $1.5 billion and operating income of $973 million for the third quarter of 2025.

SEC original ↗CME Group — Earnings release (8-K exhibit)EX-99Oct 22, 2025

Operating incomequarter

$973 million

The company reported revenue of $1.5 billion and operating income of $973 million for the third quarter of 2025.

SEC original ↗CME Group — Earnings release (8-K exhibit)EX-99Oct 22, 2025

Net incomequarter

$908 million

Net income was $908 million and diluted earnings per common share were $2.49.

SEC original ↗CME Group — Earnings release (8-K exhibit)EX-99Oct 22, 2025

EPSquarter

$2.49

Net income was $908 million and diluted earnings per common share were $2.49.

SEC original ↗CME Group — Earnings release (8-K exhibit)EX-99Oct 22, 2025

On an adjusted basis, net income was $1.0 billion and diluted earnings per common share were $2.68.

SEC original ↗CME Group — Earnings release (8-K exhibit)EX-99Oct 22, 2025

Clearing and transaction fees revenue for third-quarter 2025 totaled $1.2 billion.

SEC original ↗CME Group — Earnings release (8-K exhibit)EX-99Oct 22, 2025

Market data revenue totaled a record $203 million for third-quarter 2025.

SEC original ↗CME Group — Earnings release (8-K exhibit)EX-99Oct 22, 2025

AI analysis

Q3 2025 · reported Oct 22, 2025

Based on: Earnings release + parent 8-K + 10-Q — transcript not held

Revenue · Q3 2025
$1.5B
EX-99 · Oct 22, 2025
EPS · Q3 2025
$2.49
EX-99 · Oct 22, 2025
Net income · Q3 2025
$908M
EX-99 · Oct 22, 2025
Operating income · Q3 2025
$973M
EX-99 · Oct 22, 2025

Headline figures

MetricQ3 2025Prior qtrYear ago
Revenue$1.5 billion——
Operating income$973 million——
Net income$908 million——
EPS$2.49——

EX-99 · Oct 22, 2025

Guidance · company-stated

No guidance located in the held release

Next earningsNo verified date on fileNo date is estimated or imported

Capital allocation

Dividend$3.5B
Dividend$29.5B

As of September 30, 2025 the company had $2.6 billion in cash (including $200 million deposited with Fixed Income Clearing Corporation, which is included in other current assets) and $3.4 billion of debt.

General educational research only — not investment advice.Every figure is as stated in the held documents; values marked “computed from stated figures” are arithmetic on those stated figures. Guidance shown is the company’s own stated guidance. No price targets, no recommendations, no consensus estimates.

Event summary

Announces Third-Quarter 2025 Financial Results

Based on: Earnings release + parent 8-K + 10-Q — transcript not held

Guidance & outlook

No guidance located in the held release

Capital allocation

As of September 30, 2025 the company had $2.6 billion in cash (including $200 million deposited with Fixed Income Clearing Corporation, which is included in other current assets) and $3.4 billion of debt.

SEC original ↗CME Group — Earnings release (8-K exhibit)EX-99Oct 22, 2025

The company paid dividends during the first nine months of the year of approximately $3.5 billion.

SEC original ↗CME Group — Earnings release (8-K exhibit)EX-99Oct 22, 2025

The company has returned over $29.5 billion to shareholders in the form of dividends since the implementation of the variable dividend policy in early 2012.

SEC original ↗CME Group — Earnings release (8-K exhibit)EX-99Oct 22, 2025

During the three and nine months ended September 30, 2026, 2,047,234 and 6,432,010 shares of outstanding Class A common stock were repurchased, respectively.

SEC original ↗CME Group — 10-Q Quarterly report10-QOct 23, 2026

The remaining aggregate amount under the existing Share Repurchase Program is $ 1.0 billion as of September 30, 2026.

SEC original ↗CME Group — 10-Q Quarterly report10-QOct 23, 2026

Shares are retired upon repurchase and not held as treasury stock.

SEC original ↗CME Group — 10-Q Quarterly report10-QOct 23, 2026

Strategy & priorities

Looking ahead, we remain focused on delivering efficiencies, new products and expanded access for market users, including through our new partnership with FanDuel and 24 7 trading in our cryptocurrency futures and options.

SEC original ↗CME Group — Earnings release (8-K exhibit)EX-99Oct 22, 2025

Futures contracts based on the S P 500 Index are not sponsored, endorsed, marketed, or promoted by S P DJI, and S P DJI makes no representation regarding the advisability of investing in such products.

SEC original ↗CME Group — Earnings release (8-K exhibit)EX-99Oct 22, 2025

Other revenues include certain access and communication fees, fees for collateral management, equity membership subscription fees, and fees for trade order routing through agreements from various strategic relationships.

SEC original ↗CME Group — 10-Q Quarterly report10-QOct 23, 2026

Pricing for strategic relationships may be driven by customer levels and activity.

SEC original ↗CME Group — 10-Q Quarterly report10-QOct 23, 2026

Revenue is recognized monthly for strategic relationship arrangements as the customers receive and consume the benefits of the services.

SEC original ↗CME Group — 10-Q Quarterly report10-QOct 23, 2026

Risks & headwinds

1 Global clients continued relying on CME Group markets across all asset classes as they sought to navigate risk and pursue opportunities amid ongoing uncertainty in Q3, said Terry Duffy, Chairman and Chief Executive Officer, CME Group.

SEC original ↗CME Group — Earnings release (8-K exhibit)EX-99Oct 22, 2025

These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict.

SEC original ↗CME Group — Earnings release (8-K exhibit)EX-99Oct 22, 2025

Legal Proceedings 32 Item 1A.

SEC original ↗CME Group — 10-Q Quarterly report10-QOct 23, 2026

In addition, the company is a defendant in, and has potential for, various other legal proceedings arising from its regular business activities.

SEC original ↗CME Group — 10-Q Quarterly report10-QOct 23, 2026

Competitors

Competitors & peers

Named in the company’s own filings

Nasdaq, Inc. (NDAQ)“In addition, we cannot guarantee that others will not succeed in creating stock index futures based on information similar to that which we own or have obtained by license, or that market participants will not increasingly use other instruments, including securities and options based on the S&P, Dow Jones, Nasdaq or FTSE Russell indices, to manage or speculate on U.S.”Financial Institutions Inc. (FISI)“There is a growing array of platforms and technologies, often owned by well-capitalized financial institutions and intermediaries that are also driving internalization of client FX trade flows.”
Documents

Filings

60 documents

Earnings releases

19 documents

Presentations

0 documents

No presentations for CME Group are held in this edition of the library.

Transcripts

0 documents

No transcripts for CME Group are held in this edition of the library.

Mentioned by

1 company

Other tracked companies whose held documents mention CME Group by name or ticker. A mention is counted once per document, from the document text the library holds.

See also the earnings calendar for every tracked company’s next earnings date.